单位:[1]Chinese Acad Med Sci,Tongji Hosp,NHC Key Lab Organ Transplantat,Key Lab Organ Transplantat,Minist Educ,Ctr Biomed,Wuhan,Hubei,Peoples R China器官移植器官移植研究所生物医学研究中心华中科技大学同济医学院附属同济医院[2]Univ Libre Bruxelles, ULB Ctr Diabet Res, 808 Route Lennik, B-1070 Brussels, Belgium[3]Indiana Biosci Res Inst IBRI, Indianapolis, IN USA
SUMOylation is an evolutionarily conserved post-translational modification (PTM) that regulates protein subcellular localization, stability, conformation, transcription and enzymatic activity. Recent studies indicate that SUMOylation plays a key role in insulin gene expression, glucose metabolism and insulin exocytosis under physiological conditions in the pancreatic beta cells. Furthermore, SUMOylation is implicated in beta cell survival and recovery following exposure to oxidative stress, ER stress and inflammatory mediators under pathological situations. SUMOylation is closely regulated by the cellular redox status, and it collaborates with other PTMs such as phosphorylation, ubiquitination, and NEDDylation, to maintain beta cellular homeostasis. We hereby provide an update on recent findings regarding the role of SUMOylation in the regulation of pancreatic beta cell viability and function, and discuss its potential implication in beta cell senescence and RNA processing (e.g., pre-mRNA splicing and mRNA methylation). Through which we intend to provide novel insights into this fundamental biological process regarding both maintenance of beta cell viability and functionality, and beta cell dysfunction in diabetes mellitus.
基金:
Ministry of Science and Technology [2016YFC1305002, 2017YFC1309603]; National Natural Science Foundation of China [81530024, 91749207, 81920108009, 81770823]; NHC Drug Discovery Program [2017ZX09304022-07]; Integrated Innovative Team for Major Human Disease Programs of Tongji Medical College, Huazhong University of Science and Technology; Innovative Funding for Translational Research from Tongji Hospital; Welbio-FNRS (Fonds National de la Recherche Scientifique), Belgium; Indiana Biosciences Research Institute (IBRI), Indianapolis, Indiana, USA
第一作者单位:[1]Chinese Acad Med Sci,Tongji Hosp,NHC Key Lab Organ Transplantat,Key Lab Organ Transplantat,Minist Educ,Ctr Biomed,Wuhan,Hubei,Peoples R China
通讯作者:
通讯机构:[1]Chinese Acad Med Sci,Tongji Hosp,NHC Key Lab Organ Transplantat,Key Lab Organ Transplantat,Minist Educ,Ctr Biomed,Wuhan,Hubei,Peoples R China[2]Univ Libre Bruxelles, ULB Ctr Diabet Res, 808 Route Lennik, B-1070 Brussels, Belgium[3]Indiana Biosci Res Inst IBRI, Indianapolis, IN USA[*1]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Ctr Biomed Res,Tongji Hosp Res Bldg,Wuhan Caidian 430000,Peoples R China[*2]Univ Libre Bruxelles ULB, ULB Ctr Diabet Res, Med Fac, 808 Route Lennik, B-1070 Brussels, Belgium
推荐引用方式(GB/T 7714):
Li Na,Zhang Shu,Xiong Fei,et al.SUMOylation, a multifaceted regulatory mechanism in the pancreatic beta cells[J].SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY.2020,103:51-58.doi:10.1016/j.semcdb.2020.03.008.
APA:
Li, Na,Zhang, Shu,Xiong, Fei,Eizirik, Decio L.&Wang, Cong-Yi.(2020).SUMOylation, a multifaceted regulatory mechanism in the pancreatic beta cells.SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY,103,
MLA:
Li, Na,et al."SUMOylation, a multifaceted regulatory mechanism in the pancreatic beta cells".SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY 103.(2020):51-58